Warhound raises $200 million to engineer military dogs
The company is a collab between defense tech firm Anduril and Colossal Biosciences, the biotech startup looking to bring back the woolly mammoth.
Warhound, a new defense technology company, has secured $200 million in seed funding from investors such as Sequoia Capital to develop genetically engineered military dogs. The company is a collaboration between Anduril and Colossal Biosciences, with the goal of using Colossal’s genetics platform and Anduril’s defense technology to modify and clone military working dogs.
These genetically modified dogs would replace foreign-bred combat and security dogs, primarily Belgian Malinois and German shepherds, and would be used to replace the US Department of Defense’s current 1,600 military working dogs. If successful, Warhound’s project would represent a rare reshoring win for the Trump administration.
Brief written by urgent.news from Semafor's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
